Chris Dall

The intervention at 10 critical-access hospitals was associated with a small but potentially clinically significant reduction in ASB treatment.

Study, report highlight threat of antimicrobial resistance in refugees

After spiking during the COVID-19 pandemic, rates of HAIs in US acute-care hospitals fell in 2023.

The infections were caused by Trichophyton mentagrophytes type VII (TMVII), a sexually transmitted fungus that causes ringworm.

Data from US pharmacies indicates the volume of outpatient antibiotic prescriptions, after falling sharply in 2020 and 2021, rose to 2019 levels by the end of 2022.

CDC: Onions likely cause of McDonald's E coli outbreak

Analysis finds 20% of children with pneumonia don't receive antibiotics

WHO report shows global tuberculosis cases are rising

FDA approves new oral antibiotic for urinary tract infections

More cases, hospitalizations reported in McDonald's-linked E coli outbreak

Researchers found that a daptomycin-resistance mutation in vancomycin-resistant Enterococcus faecium is linked to use of rifaximin, an antibiotic prescribed for patients with liver cirrhosis.

The vaccine advisory group voted 14 to 1 in favor of lowering the age for pneumococcal vaccination from 65 to 50. 

The study authors say knowledge about antibiotic-related harms will help patients, providers, and antibiotic stewardship programs.

Multistate E coli outbreak tied to McDonald's Quarter Pounders

The Italian government will contribute $21 million over 3 years to support CARB-X’s efforts to advance early-stage development of innovative new products for drug-resistant pathogens.

After surging during the pandemic, rates of carbapenem-resistant gram-negative bacteria in critically ill patients have declined but remain higher than pre-pandemic rates.

A trial conducted in 7 countries found that a 7-day course of antibiotics for patients with bloodstream infections is non-inferior to a 14-day course.

Spike in detection of multidrug-resistance gene reported in New York hospitals

FDA report shows small decline in sales of antibiotics for food-producing animals

The project will begin with research into an at-home, inhalable treatment containing probiotics and prebiotics that can combat lung infections caused by Pseudomonas aeruginosa.